A low-emulsifier-containing diet led to a threefold increased likelihood of improvement in symptoms of Crohn’s disease ...

Patients with Crohn's disease and long-term ileostomy experience endoscopic recurrence, with ileal involvement and prior ...

Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...

In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape ...

In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new to ...

Eli Lilly (LLY) has won Health Canada approval for Omvoh (mirikizumab) in patients with Crohn’s disease, the company said on ...

Poo transplants are being used to help people battling painful gut conditions that are on the rise in Australia, with the treatment being tested for a range of illnesses including long Covid.

Eli Lilly Canada Inc. (Lilly Canada) announced today that Health Canada has approved Omvoh® (mirikizumab) for CD, which will ...

The interaction between a common gene variant and gut microbes may trigger chronic inflammation in ulcerative colitis, new ...